143 related articles for article (PubMed ID: 2306688)
1. Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group.
Wollner N; Mandell L; Filippa D; Exelby P; McGowan N; Lieberman P
Cancer; 1990 Mar; 65(6):1438-44. PubMed ID: 2306688
[TBL] [Abstract][Full Text] [Related]
2. Nasal-paranasal-oronasopharyngeal lymphomas in childhood: the role of staging system on prognosis.
Yariş N; Kutluk T; Yalçin B; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2000; 17(5):345-53. PubMed ID: 10914044
[TBL] [Abstract][Full Text] [Related]
3. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease.
Proulx GM; Caudra-Garcia I; Ferry J; Harris N; Greco WR; Kaya U; Chan A; Wang CC
Am J Clin Oncol; 2003 Feb; 26(1):6-11. PubMed ID: 12576916
[TBL] [Abstract][Full Text] [Related]
5. LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
Duque-Hammershaimb L; Wollner N; Miller DR
Cancer; 1983 Jul; 52(1):39-43. PubMed ID: 6573941
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
7. Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Vecchi V; Serra L; Pession A; Rosito P; Paolucci P; Burnelli R; Vivarelli F; Mancini AF; Paolucci G
Pediatr Hematol Oncol; 1986; 3(3):217-28. PubMed ID: 3153234
[TBL] [Abstract][Full Text] [Related]
8. Primary lymphomas of the nasal cavity and paranasal sinuses.
Robbins KT; Fuller LM; Vlasak M; Osborne B; Jing BS; Velasquez WS; Sullivan JA
Cancer; 1985 Aug; 56(4):814-9. PubMed ID: 4016673
[TBL] [Abstract][Full Text] [Related]
9. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
[TBL] [Abstract][Full Text] [Related]
10. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. A report of 18 cases with stage IE disease.
Tran LM; Mark R; Fu YS; Calcaterra T; Juillard G
Am J Clin Oncol; 1992 Jun; 15(3):222-5. PubMed ID: 1590274
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
13. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
14. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
15. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group.
Jenkin RD; Anderson JR; Chilcote RR; Coccia PF; Exelby PR; Kersey JH; Kushner JH; Meadows AT; Siegel SE; Sposto R
J Clin Oncol; 1984 Feb; 2(2):88-97. PubMed ID: 6366148
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
[TBL] [Abstract][Full Text] [Related]
17. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
[TBL] [Abstract][Full Text] [Related]
18. Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
Pichler E; Jürgenssen OA; Radaszkiewicz T; Reinartz G; Mutz I; Urban C; Krepler P; Schmidmeier W; Becker H; Kundi M
Cancer; 1982 Dec; 50(12):2740-6. PubMed ID: 6897203
[TBL] [Abstract][Full Text] [Related]
19. End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity.
Murphy SB; Hustu HO; Rivera G; Berard CW
J Clin Oncol; 1983 May; 1(5):326-30. PubMed ID: 6668503
[TBL] [Abstract][Full Text] [Related]
20. [Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Prats Viñas J; Gallego Melcón S; Pérez Payarols J; Macía Martí J; Sánchez de Toledo J
An Esp Pediatr; 1987 Jan; 26(1):15-21. PubMed ID: 3826937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
